0010B |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Blood |
0010SP |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Serum/Plasma |
0010U |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Urine |
0014B |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Blood |
0014SP |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Serum/Plasma |
0014U |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Urine |
0015B |
2-methyl AP-237 & AP-238, Blood |
0015SP |
2-methyl AP-237 & AP-238, Serum/Plasma |
0015U |
2-methyl AP-237 & AP-238, Urine |
0205B |
Acetyl Fentanyl, Blood |
0205SP |
Acetyl Fentanyl, Serum/Plasma |
0205U |
Acetyl Fentanyl and Metabolite, Urine |
0570B |
Designer Benzodiazepines, Blood |
0570SP |
Designer Benzodiazepines, Serum/Plasma |
0570U |
Designer Benzodiazepines (Qualitative), Urine |
0771B |
Brorphine, Blood |
0771SP |
Brorphine, Serum/Plasma |
0771U |
Brorphine, Urine |
1021B |
Substituted Cathinone Panel, Blood |
1021SP |
Substituted Cathinone Panel, Serum/Plasma |
1021U |
Substituted Cathinone Panel, Urine |
1022B |
Eutylone, Blood |
1022SP |
Eutylone, Serum/Plasma |
1022U |
Eutylone (Qualitative), Urine |
1476B |
Delta-8 Cannabinoids Panel (DUID/DRE), Blood (Forensic) |
1479B |
Delta-8 and Delta-9 Cannabinoids Panel (DUID/DRE), Blood (Forensic) |
1480B |
Designer Opioids, Blood |
1480SP |
Designer Opioids, Serum/Plasma |
1480U |
Designer Opioids (Qualitative), Urine |
1483B |
Desalkylgidazepam, Blood |
1483SP |
Desalkylgidazepam, Serum/Plasma |
1483U |
Desalkylgidazepam (Qualitative), Urine |
1858B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
1858FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1858TI |
Drugs of Abuse (10 Panel) and Alcohol Screen, Tissue |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1861B |
Drugs of Abuse Screen (7 Panel), Blood |
1861U |
Drugs of Abuse Screen (6 Panel), Urine |
1864B |
Drugs of Abuse Screen (11 Panel), Blood |
1864FL |
Drugs of Abuse Screen (11 Panel), Fluid |
1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
1864SP |
Drugs of Abuse Screen (11 Panel), Serum/Plasma |
1864TI |
Drugs of Abuse Screen (11 Panel), Tissue |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
1874B |
Drug Screen (10 Panel), Blood |
1874U |
Drug Screen (9 Panel), Urine |
1876B |
Drug Screen - Expanded, Blood |
1876FL |
Drug Screen - Expanded, Fluid |
1876SP |
Drug Screen - Expanded, Serum/Plasma |
1876U |
Drug Screen - Expanded, Urine |
2626B |
Bath Salts Panel (Qualitative), Blood |
2626SP |
Bath Salts Panel (Qualitative), Serum/Plasma |
2626U |
Bath Salts Panel (Qualitative), Urine |
2760ME |
Methadone and Metabolite (Qualitative), Meconium |
3064B |
Mitragynine, Blood |
3064SP |
Mitragynine, Serum/Plasma |
3078U |
Mitragynine (Qualitative), Urine |
3168B |
Nitazenes Panel, Blood |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
4047B |
Pyrrolidinophenone Panel, Blood |
4047SP |
Pyrrolidinophenone Panel, Serum/Plasma |
4282SP |
Synthetic Cannabinoids (Qualitative), Serum/Plasma |
4283U |
Synthetic Cannabinoid Metabolites-Expanded (Qualitative), Urine |
6904ME |
Drugs of Abuse Screen (7 Panel), Meconium |
6946H |
Drugs of Abuse Screen (9 Panel), Hair |
8030B |
Drug Facilitated Crime Panel, Blood (Forensic) |
8030SP |
Drug Facilitated Crime Panel, Serum/Plasma (Forensic) |
8030U |
Drug Facilitated Crime Panel, Urine (Forensic) |
8041B |
Postmortem, Basic w/Vitreous Alcohol Confirmation, Blood (Forensic) |
8050U |
Postmortem, Urine Screen Add-On (6-MAM Quantification only) (Forensic) Overview: Add-On Test |
8051B |
Postmortem, Basic, Blood (Forensic) |
8051FL |
Postmortem, Basic, Fluid (Forensic) |
8051SP |
Postmortem, Basic, Serum/Plasma (Forensic) |
8051TI |
Postmortem, Basic, Tissue (Forensic) |
8051U |
Postmortem, Basic, Urine (Forensic) |
8054B |
NMS TotalTox™ Panel, Blood (Forensic) Overview: Forensic Analysis; Exclusion Screen; This test is New York State approved. |
8061B |
Postmortem, Basic w/o Alcohol, Blood (Forensic) |
8061TI |
Postmortem, Basic w/o Alcohol, Tissue (Forensic) |
8061U |
Postmortem, Basic w/o Alcohol, Urine (Forensic) |
8070U |
DUID/DRE Panel (w/Alcohol) (Qualitative), Urine (Forensic) |
8071U |
DUID/DRE Panel (Qualitative), Urine (Forensic) |
8083B |
Postmortem, Basic w/Vitreous Alcohol and 6-MAM Confirmation, Blood (Forensic) |
8098B |
Drug Screen (GC/MS), Blood |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8098U |
Drug Screen (GC/MS), Urine |
8150B |
DUID/DRE Panel, Blood (Forensic) |
8151B |
DUID/DRE Panel (w/Alcohol), Blood (Forensic) |
8158B |
DUID/DRE Expanded Drug Screen (w/Alcohol), Blood (Forensic) |
8159B |
DUID/DRE Expanded Drug Screen, Blood (Forensic) |
8170U |
DUID/DRE Panel (w/Alcohol), Urine (Forensic) |
8171U |
DUID/DRE Panel, Urine (Forensic) |
8670ME |
Opiates - Total (Conjugated/Unconjugated) (Qualitative), Meconium |
8756B |
Novel Psychoactive Substances (NPS) Screen 1, Blood |
8756SP |
Novel Psychoactive Substances (NPS) Screen 1, Serum/Plasma |
8756U |
Novel Psychoactive Substances (NPS) Screen 1, Urine |
8894OF |
Methadone and Metabolite (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9105B |
Acetyl Fentanyl Screen, Blood |
9105SP |
Acetyl Fentanyl Screen, Serum/Plasma |
9105U |
Acetyl Fentanyl Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |